SLN Status Improves Adjuvant Therapy Decision–Making in Patients With Clinical Stage IIB/C Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: a population-based analysis
J Am Acad Dermatol 2022 Nov 25;[EPub Ahead of Print], CE Sharon, RJ Straker, PA Gimotty, EY Chu, TC Mitchell, JT Miura, MA Marchetti, EK Bartlett, GC KarakousisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.